,,ii  #aagth ,,congress  #b;d ,session  
,s4 #dcea  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,june #f1      
#bjbb,mr4 ,romney 7for himself1 ,ms4    
,hassan1 ,ms4 ,rosen1 and ,mr4          
,hickenlooper7 introduced the following 
bill2 which was read twice and referred 
to the ,committee on ,health1           
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to amend the ,federal ,food1   
,drug1 and ,cosmetic ,act to clarify the
 conditions under which the ,secretary  
of ,health and ,human ,services can     
approve generic drug applications with  
labeling temporarily different than the 
brand name drug1 and for other purposes4
  #a4 ,short title ,this ,act may be    
cited as the ,enhanced ,access to       
,affordable ,medicines ,act of #bjbb4   
#b4 ,enhancing access to affordable     
medicines ,section #eje7;j77#aj77;,a7 of
 the ,federal ,food1 ,drug1 and         
,cosmetic ,act 7#ba ,u4,s4,c4           
#cee7;j77#aj77;,a77 is amended by       
striking clauses 7i7 through 7iv7 and   

inserting the following3  7i7 a revision
 to the labeling of the listed drug has 
been approved by the ,secretary within  
#ij days of when the application is     
otherwise eligible for approval under   
this subsection2  7ii7 the sponsor of   
the application agrees to submit revised
 labeling for the drug that is the      
subject of the application not later    
than #fj days after approval under this 
subsection of the application2 and      
7iii7 the labeling revision described   
under clause 7i7 does not include a     
change to the #8,warnings' section of   
the labeling4  4